Business of Cannabis Europe
SOMAĆ Pharmaceuticals awarded ā¬2.7M in funding from Portugal 2020 Grant
SOMAĆ Pharmaceuticals Unipessoal LDA has received an innovative products grant of 2.7 million euros by the Portugal 2020 committee. This
SOMAĆ Pharmaceuticals Unipessoal LDA has received an innovative products grant of 2.7 million euros by the Portugal 2020 committee. This
Guy Chamberland, PhD, Chief Science Officer and Interim CEO of Tetra Bio-Pharma joined us for a Quick Hits conversation about medical cannabis,
We won’t spam you
Ā© 2024 Prohibition Holdings Ltd. All Rights Reserved.
Ā© 2023 Prohibition Holdings Ltd. All Rights Reserved.